Scott Stirn
8Patents
4h-index
23Co-inventors
53Inventor score
Filing activity: Jul 22, 2009 → Jan 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8580841B2 | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders | Emerging Cross-Sectional Technologies | 17 | Active |
| US8980891B2 | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | Human Necessities | 10 | Active |
| US9522133B2 | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders | Emerging Cross-Sectional Technologies | 9 | Active |
| US9085581B2 | Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof | Human Necessities | 6 | Active |
| US9365521B2 | Non-hygroscopic salts of 5-HT2C agonists | Chemistry; Metallurgy | 3 | Active |
| US9248133B2 | Salts of lorcaserin with optically active acids | Chemistry; Metallurgy | 2 | Active |
| US10226471B2 | Modified-release dosage forms of 5-HT2C agonists useful for weight management | Chemistry; Metallurgy | 1 | Active |
| US10463676B2 | Modified-release dosage forms of 5-HT2C agonists useful for weight management | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.